ARCT R&D to Revenue
Arcturus Therapeutics Holdings Inc · R&D to Revenue
ARCT R&D to Revenue
Latest reported591.92%period ending
ARCT Quarterly R&D/Revenue (0.00% → 591.92%)
Latest values, visible window
High-resolution chart · PNG
ARCT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 591.9229% | |
| 3,430.3279% | |
| 794.4174% | |
| 135.6481% | |
| 120.6814% | |
| 118.7564% | |
| 208.4762% | |
| 100.8218% | |
| 127.6079% | |
| 164.3444% | |
| 146.0244% | |
| 117.7541% | |
| 500.694% | |
| 64.4803% | |
| 16.8323% | |
| 281.9059% | |
| 140.9552% | |
| 856.0831% | |
| 563.2206% | |
| 1,862.8642% | |
| 2,282.8086% | |
| 2,353.0795% | |
| 1,085.1653% | |
| 758.6369% | |
| 342.1189% | |
| 299.2063% | |
| 404.1105% | |
| 212.5678% | |
| 71.5946% | |
| 168.3678% | |
| 63.9699% | |
| 115.9509% | |
| 177.0746% | |
| 166.4977% | |
| 87.3673% | |
| 32.1299% | |
| 38.3675% | |
| 53.6319% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |